These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 34556024)

  • 1. CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review.
    Foruzandeh Z; Zeinali-Sehrig F; Nejati K; Rahmanpour D; Pashazadeh F; Seif F; Alivand MR
    Cell Mol Biol Lett; 2021 Sep; 26(1):41. PubMed ID: 34556024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
    Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
    Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of circular RNA as competing endogenous RNA in ovarian cancer (Review).
    Ye W; Xiang N; Wang Q; Lu Y
    Int J Mol Med; 2024 May; 53(5):. PubMed ID: 38456562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
    Sheng R; Li X; Wang Z; Wang X
    Cancer Lett; 2020 Mar; 473():139-147. PubMed ID: 31904484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.
    Najafi S
    J Cancer Res Clin Oncol; 2023 May; 149(5):2211-2234. PubMed ID: 36053324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA; a new biomarker for breast cancer: A systematic review.
    Jahani S; Nazeri E; Majidzadeh-A K; Jahani M; Esmaeili R
    J Cell Physiol; 2020 Jul; 235(7-8):5501-5510. PubMed ID: 31985056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiling and bioinformatics analyses reveal differential circular RNA expression in ovarian cancer.
    Wang J; Wu A; Yang B; Zhu X; Teng Y; Ai Z
    Gene; 2020 Jan; 724():144150. PubMed ID: 31589961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentially expression and function of circular RNAs in ovarian cancer stem cells.
    Sohn EJ
    J Ovarian Res; 2022 Aug; 15(1):97. PubMed ID: 35978436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircRNA FGFR3 induces epithelial-mesenchymal transition of ovarian cancer by regulating miR-29a-3p/E2F1 axis.
    Zhou J; Dong ZN; Qiu BQ; Hu M; Liang XQ; Dai X; Hong D; Sun YF
    Aging (Albany NY); 2020 Jul; 12(14):14080-14091. PubMed ID: 32668414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of downregulated circRNAs from tissue and plasma of patients with gastric cancer and construction of a circRNA-miRNA-mRNA network.
    Liu J; Li Z; Teng W; Ye X
    J Cell Biochem; 2020 Nov; 121(11):4590-4600. PubMed ID: 32052496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circRNA-UBAP2 promotes the proliferation and inhibits apoptosis of ovarian cancer though miR-382-5p/PRPF8 axis.
    Xu Q; Deng B; Li M; Chen Y; Zhuan L
    J Ovarian Res; 2020 Jul; 13(1):81. PubMed ID: 32690086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircPLEKHM3 acts as a tumor suppressor through regulation of the miR-9/BRCA1/DNAJB6/KLF4/AKT1 axis in ovarian cancer.
    Zhang L; Zhou Q; Qiu Q; Hou L; Wu M; Li J; Li X; Lu B; Cheng X; Liu P; Lu W; Lu Y
    Mol Cancer; 2019 Oct; 18(1):144. PubMed ID: 31623606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNAs: Promising biomarkers for cancer diagnosis and prognosis.
    Wei G; Zhu J; Hu HB; Liu JQ
    Gene; 2021 Mar; 771():145365. PubMed ID: 33346098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein IGF2BP2 enhances circ_0000745 abundancy and promotes aggressiveness and stemness of ovarian cancer cells via the microRNA-3187-3p/ERBB4/PI3K/AKT axis.
    Wang S; Li Z; Zhu G; Hong L; Hu C; Wang K; Cui K; Hao C
    J Ovarian Res; 2021 Nov; 14(1):154. PubMed ID: 34774079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNAs as biomarkers and therapeutic targets in cancer.
    Beilerli A; Gareev I; Beylerli O; Yang G; Pavlov V; Aliev G; Ahmad A
    Semin Cancer Biol; 2022 Aug; 83():242-252. PubMed ID: 33434640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA profiling reveals circEXOC6B and circN4BP2L2 as novel prognostic biomarkers in epithelial ovarian cancer.
    Ning L; Long B; Zhang W; Yu M; Wang S; Cao D; Yang J; Shen K; Huang Y; Lang J
    Int J Oncol; 2018 Dec; 53(6):2637-2646. PubMed ID: 30272264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circular RNA as biomarkers for acute ischemic stroke: A systematic review and meta-analysis.
    Zhang X; Wan M; Min X; Chu G; Luo Y; Han Z; Li W; Xu R; Luo J; Li W; Yang Y; Ma Y; Jiao L; Wang T
    CNS Neurosci Ther; 2023 Aug; 29(8):2086-2100. PubMed ID: 37186176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of hsa_circ_0007874 suppresses the progression of ovarian cancer by regulating the miR-760/SOCS3 pathway.
    Li L; Yu P; Zhang P; Wu H; Chen Q; Li S; Wang Y
    Cancer Med; 2020 Apr; 9(7):2491-2499. PubMed ID: 32023009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA circ-BNC2 (hsa_circ_0008732) inhibits the progression of ovarian cancer through microRNA-223-3p/ FBXW7 axis.
    Liu T; Yuan L; Zou X
    J Ovarian Res; 2022 Aug; 15(1):95. PubMed ID: 35965327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).
    Zhao X; Wang Y; Yu Q; Yu P; Zheng Q; Yang X; Gao D
    Int J Mol Med; 2020 Nov; 46(5):1611-1632. PubMed ID: 33000182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.